Science & Technology

AHDS: Thyroid-Hormone Transport and Access to Tiratricol

AHDS: Thyroid-Hormone Transport and Access to Tiratricol

Why in news?

Seven Indian children with Allan-Herndon-Dudley syndrome are scheduled to receive a year's supply of tiratricol free of cost on 30 November 2026. A Hyderabad-led initiative arranged the medicine through pharmacy compounding in the Netherlands. The Hindu reported an estimated annual compounded cost of about ₹2.5 lakh per child. It compared this with reported commercial treatment costs of ₹4.68 crore to ₹9 crore a year. The initiative concerns access to a medicine used to manage the effects of excess thyroid hormone in the body.

A disorder of thyroid-hormone transport

Allan-Herndon-Dudley syndrome (AHDS) is a rare genetic disorder that affects brain development and movement. It is also called MCT8 deficiency. The SLC16A2 gene provides instructions for the MCT8 protein. This protein transports thyroid hormone into cells, including nerve cells in the developing brain.

The thyroid is a gland in the lower neck. One of its hormones is triiodothyronine, called T3. Thyroid hormones help regulate metabolism: the chemical processes through which the body uses energy and maintains its functions. T3 also has an important role in the development of the nervous system.

Changes in SLC16A2 can impair the transporter's function. Parts of the brain then receive too little thyroid hormone, while excess T3 circulates in the blood. The resulting condition combines problems in brain development with harmful effects of excess hormone elsewhere in the body. Peripheral thyrotoxicosis refers to these effects outside the central nervous system.

Why inheritance matters

AHDS has an X-linked pattern of inheritance. The relevant gene is on the X chromosome. Males generally have one X chromosome, so one disease-causing altered copy can produce the condition. Females with one altered copy can be carriers. A father gives his Y chromosome to a son; the son's X chromosome comes from his mother.

Affected children can have low muscle tone, muscle weakness and severe limits on movement. Care therefore involves several needs, including nutrition, development and management of thyroid-hormone effects. The transport problem explains why doctors assess hormone levels alongside the child's clinical condition.

How tiratricol is used

Tiratricol, also called TRIAC, is similar to T3. It can enter cells without relying on the MCT8 transporter. The European Union authorised the tiratricol product Emcitate in 2025 for peripheral thyrotoxicosis in people with MCT8 deficiency.

The European Medicines Agency describes a main study involving 46 children and adults. Average blood T3 levels fell after 12 months of treatment. Supporting data showed small improvements in signs such as an increased heart rate and high blood pressure. Treatment requires specialist supervision and monitoring of hormone levels.

What pharmacy compounding changes

Pharmacy compounding means preparing a medicine by combining, mixing or altering ingredients for a patient's needs. The active pharmaceutical ingredient supplies the medicine's intended drug action. A pharmacist prepares it in a suitable formulation and checks the preparation's quality.

In this initiative, Transvaal Pharmacy in The Hague prepared tiratricol with support from the Pharmaceutical Accountability Foundation. Hyderabad paediatrician Sivaranjani Santosh and Access to Medicines India helped arrange access for the families. The report says individual import permissions cover one year of treatment. Supplies are planned in two batches because the compounded preparation has a six-month shelf life.

Making the active ingredient affordable is one part of access. Reliable preparation, documentation, storage and a continuing supply are also needed. These tasks connect the pharmacy's work with the importing families and the doctors supervising treatment.

Conclusion

The planned supply provides a practical route to treatment for seven children. The next steps are the scheduled handover, supervised use and continuity of supply. The case also shows how pharmacy preparation and import arrangements can affect access to medicines for rare conditions.

Sources

Lead illustration: Clarity · AI illustration of a representative pharmacy-compounding workbench.

Prelims MCQ Practice

Evaluate Your Retention

Assess your readiness with 3 high-yield multiple-choice questions on this article.

Mark your answers, submit, and see the key with explanations. Answers count only toward anonymous totals — nothing is linked to you, and it resets when you close this tab.

Practice questions 0 of 3 answered

Your result

0 / 3

Only anonymous totals are kept — nothing is linked to you. This resets when the tab closes.

1.

In MCT8 deficiency, how can low thyroid-hormone availability in parts of the brain coexist with excess T3 in the blood?

2.

With reference to X-linked inheritance, consider the following statements:

1.A son receives his X chromosome from his mother.
2.A father passes his X chromosome directly to his son.

Which of the statements given above is/are correct?

3.

Pharmacy compounding refers to:

Answer all 3 questions, then submit.
Daily news News Blitz Daily quiz Prelims PYQs Live Economic Data Subject notes How to prepare for UPSC Books and NCERTs Syllabus Exam pattern Eligibility and attempts Previous Year Papers Free Downloads Shorts Sign in